Previous 10 | Next 10 |
Two of Five Patients Enrolled for the Study IRVINE, CA / ACCESSWIRE / August 25, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has enrolled the first two patients for its first-in...
Gainers: Hancock Jaffe Laboratories (NASDAQ: HJLI ) +127% . More news on: Hancock Jaffe Laboratories, Inc., Harpoon Therapeutics, Inc., ShiftPixy, Inc., Stocks on the move, , Read more ...
4 Biotech Penny Stocks To Watch Right Now One of the top sectors for penny stocks and blue-chips alike has been biotechnology and healthcare. Obviously, the global pandemic and search for a coronavirus vaccine upped the attention on this sector in 2020. Aside from that, however, we’...
VenoValve Patients Continue to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / August 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that two additional VenoV...
Hancock Jaffe Laboratories ( HJLI +12.2% ) has regained compliance with Nasdaq stockholder's equity equity requirement for the continued listing of its shares. More news on: Hancock Jaffe Laboratories, Inc., Healthcare stocks news, Stocks on the move, Read more ...
IRVINE, CA / ACCESSWIRE / August 10, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that HJLI has received formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has e...
Are These Robinhood Penny Stocks On Your Radar Right Now? After the rollercoaster week last week, penny stocks are in an even brighter light. Typically the summer months are slower but this is “the year of the pandemic” of course. It would seem like there are no holds barred at...
Patient Selection to Begin Immediately for CoreoGraft Study IRVINE, CA / ACCESSWIRE / July 23, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Italian Hospital Asuncion in Paraguay ha...
IRVINE, CA / ACCESSWIRE / July 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the closings of an underwritten public offering, the full exercise of the underwriter's over-allotment option, ...
Hancock Jaffe Laboratories ( HJLI +0.8% ) prices $5.6M offering , which includes underwritten public offering and private placement of units. More news on: Hancock Jaffe Laboratories, Inc., Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Hancock Jaffe Laboratories Inc. Company Name:
HJLI Stock Symbol:
NASDAQ Market:
Company Now Trading Under Ticker Symbol "NVNO" IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully comple...
Live webinar followed by Q&A on Monday, September 27 th at 1:00 PM ET with Robert Berman Chief Executive Officer of Hancock Jaffe Laboratories IRVINE, CA / ACCESSWIRE / September 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a medic...
- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 - - Development strategy to focus on venous disease and advancement of the VenoValve® - - Initiated development of second product for the treatment of veno...